Stephen Kent to Placebos
This is a "connection" page, showing publications Stephen Kent has written about Placebos.
Connection Strength
0.036
-
The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial. Lancet HIV. 2018 05; 5(5):e221-e230.
Score: 0.036
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.